Perceptions of patients with early stage breast cancer toward research biopsies.

"Conflict of Interest Disclosures Jose Pablo Leone reports grants from Kazia Therapeutics and Merck, outside the submitted work. Zsofia K. Stadler reports that an immediate family member serves as a consultant in ophthalmology for Adverum Biotechnologies, Allergan, Genentech/Roche, Novartis, Neurogene, Gyroscope Tx, Optos Plc, Regeneron, RegenexBio, and Spark Therapeutics. Jeffrey M. Peppercorn reports grants from Pfizer; personal fees from Athenex, Abbott Labs, and GlaxoSmithKline, outside the submitted work; and that his spouse is an employee of GlaxcoSmithKline and holds stock in the company. Eric P. Winer reports institutional research support from Genentech/Roche and personal fees from Carrick Therapeutics, G1 Therapeutics, Genentech/Roche, Genomic Health, GlaxoSmithKline, Jounce, Leap, Lilly, Novartis, Seattle Genetics, and Syros, outside the submitted work. Nancy U. Lin reports institutional research support from Genentech, Pfizer, Merck, and Seattle Genetics; and personal fees from Puma, Seattle Genetics, Daichii‐Sankyo, AstraZeneca, Denali Therapeutics, and the California Institute for Regenerative Medicine, outside the submitted work. The remaining authors made no disclosures."

"Breast Oncology Program, Dana‐Farber Cancer Institute 10.13039/100007886"